Felix v. Symantec Corporation

District Court, N.D. California·Decided October 2, 2019·No. 3:18-cv-02902·Unknown

Opinion

1 2 3 4 5 6 IN THE UNITED STATES DISTRICT COURT 7 FOR THE NORTHERN DISTRICT OF CALIFORNIA 8 9 10 SEB INVESTMENT MANAGEMENT AB, individually and on behalf of all 11 others similarly situated, No. C 18-02902 WHA 12 Plaintiff, 13 v. ORDER RE MOTION FOR LEAVE TO FILE FIRST 14 SYMANTEC CORPORATION, AMENDED COMPLAINT GREGORY S. CLARK, NICHOLAS R. 15 NOVIELLO, and MARK S. GARFIELD, 16 Defendants. / 17 18 INTRODUCTION 19 In this securities action, lead plaintiff moves for leave to file first amended complaint. 20 To the extent stated below, the motion is GRANTED. 21 STATEMENT 22 Previous orders have stated the facts of this case. In short, defendant Symantec 23 Corporation is a company that sells cybersecurity products and services. In early 2016, 24 Symantec divested Veritas Software, a company it had acquired for $13.5 billion. In June 2016, 25 Symantec announced the $4.65 billion acquisition of a privately-held network-security firm 26 called Blue Coat Systems, Inc. Blue Coat’s top management team then took control of 27 Symantec, with defendants Gregory Clark and Nicholas Noviello assuming the positions of 28 Symantec’s CEO and CFO, respectively. Defendant Mark Garfield, Symantec’s Chief 1 2016, Symantec acquired Lifelock, Inc., a consumer identity-protection company for $2.3 2 billion. In connection with this acquisition, Symantec increased its revenue and income targets 3 for executive compensation (Consolidated Compl. ¶¶ 19–40). 4 Symantec reported strong financial performance and the success of the Blue Coat and 5 Lifelock acquisitions in its SEC filings for fiscal years 2017 and 2018. In the Form 10-K for the 6 fiscal year 2017, defendants affirmed that Symantec’s financial statements were GAAP 7 compliant. These revenues exceeded CEO Clark and CFO Noviello’s 2017 executive 8 compensation plan targets and they accordingly received millions of dollars in equity awards 9 (id. ¶¶ 131–40, 183, 187–89, 195–96). 10 The leadership shakeup that followed the Blue Coat acquisition resulted in negative 11 changes in Symantec’s policies and practices concerning financial reporting. Specifically 12 defendants engaged in improper revenue recognition practices in violation of GAAP and 13 improperly recorded ordinary operating expenses as “transition costs” (id. ¶¶ 64–90). 14 In May 2018, Symantec announced that its Audit Committee had begun an internal 15 investigation. Symantec’s stock declined by over 33 percent following the announcement (id. 16 ¶¶ 159). Individuals then filed two lawsuits in this district on behalf of themselves and a 17 putative class of similarly-situated investors. An August 2018 order consolidated the two 18 actions and appointed SEB Investment Management AB as lead plaintiff in the consolidated 19 action (Dkt. No. 75). 20 Also in August 2018, Symantec released its earnings for the first quarter of fiscal year 21 2019. At the same time, it announced the internal investigation was “ongoing.” Symantec’s 22 stock price dropped another eight percent (Consolidated Compl. ¶¶ 167, 288). 23 In September 2018, Symantec concluded its investigation and announced that it found 24 relatively weak and informal processes with respect to some aspects of the review. The 25 investigation also uncovered that $12 million of a $13 million transaction previously recognized 26 as revenue in the fourth quarter of fiscal year 2018 should have been deferred. Symantec also 27 announced that in September 2017 it had “initiated a review by an outside accounting firm of, 28 1 and took other steps to enhance, the Company’s policies and procedures regarding non-GAAP 2 measures” (id. ¶¶ 167–85). 3 In October 2018, an order approved SEB’s selection of lead counsel. A consolidated 4 complaint followed and defendants filed motions to dismiss in December 2018, which were 5 granted (Dkt. Nos. 88, 103, 114, 137). A June 2019 order granted a motion to relate Lee v. 6 Clark (Case No. 18-cv-02902), a derivative action. In the derivative action, plaintiff moved to 7 seal portions of the verified stockholder derivative complaint. A July 2019 order denied in part 8 and granted in part the motion (Dkt. Nos. 15, 23). Following the unsealing of portions of the 9 derivative complaint, plaintiff in the instant action filed an amended motion for leave to file a 10 first amended complaint. Defendants oppose. This order follows full briefing and oral 11 argument. 12 ANALYSIS 13 FRCP 15(a)(2) permits a party to amend its pleading with the court’s leave, advising that 14 “[t]he court should freely give leave when justice so requires.” In ruling on a motion for leave 15 to amend, courts consider: (1) bad faith, (2) undue delay, (3) prejudice to the opposing party, (4) 16 futility of amendment, and (5) whether plaintiff has previously amended his complaint. Allen v. 17 City of Beverly Hills, 911 F.2d 367, 373 (9th Cir. 1990). For purposes of assessing futility on 18 this motion, the legal standard is the same as it would be on a motion to dismiss under FRCP 19 12(b)(6). Miller v. Rykoff-Sexton, Inc., 845 F.2d 209, 214 (9th Cir. 1988). 20 To state a claim under Section 10(b) of the Securities Exchange Act of 1934, plaintiff 21 must plead: (i) a material misrepresentation or omission; (ii) scienter; (iii) a connection with the 22 purchase or sale of a security; (iv) reliance; (v) economic loss; and (vi) loss causation. Dura 23 Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336, 341–42 (2005). 24 The proposed first amended complaint seeks to amend by including new facts 25 demonstrating the materiality of defendants’ revenue recognition misconduct, adding new 26 details regarding scienter, and alleging misrepresentations regarding the Blue Coat integration. 27 28 1 1. REVENUE RECOGNITION. 2 According to the proposed amended complaint, defendants engaged in various revenue 3 recognition practices that violated GAAP. Such alleged improper revenue recognition practices 4 include failure to defer revenue, double-booking sales, and recognizing revenue for sales in 5 which a purchase order had not yet been issued. 6 A. Materiality. 7 The order granting defendants’ motion to dismiss did so on the ground that plaintiff had 8 not provided sufficient facts to demonstrate the materiality of defendants’ improper revenue 9 recognition practices. Plaintiff has now met the requirement for pleading materiality. 10 First, the previous complaint alleged defendants identified a transaction where $13 11 million had been recognized as revenue in the fourth quarter of fiscal year 2018 but for which 12 $12 million should have been deferred to the following quarter. Defendants subsequently 13 revised the preliminary financial results to take this deferral into account. The order granting 14 defendants’ motion to dismiss highlighted the fact that the deferral reduced the company’s 15 fourth quarter revenue by less than one percent, too tiny to show materiality. 16 Plaintiff has now added further allegations stating the $12 million materially affected 17 Symantec’s operating income. Specifically, Symantec reported $49 million of operating 18 income for fiscal year 2018, which allegedly would have been reported as $61 million if 19 defendants had not revised their preliminary financial results. This would have accordingly 20 lowered operating income for the fiscal year by 20%.

Free access — add to your briefcase to read the full text and ask questions with AI

Felix v. Symantec Corporation, (N.D. Cal. 2019).

Felix v. Symantec Corporation (Felix v. Symantec Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related